Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
| NAV as of Dec 04, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
|---|---|---|---|
| ₹17.423+0.28% 1 day change | 29.09% p.a. | App exclusive | ₹1,967 Cr |
| AUM (Fund size) | ₹1,967 Cr |
| Exit load | 1.0% Exit load of 1%, if redeemed within 30 days.! |
| Lock-in Period | Nil |
| Age | 2 yrs 2 m since Sep 14, 2023 |
| Benchmark | BSE Healthcare TRI |
| Min. investment | SIP: ₹500 & Lumpsum: ₹1000 |
| Expense ratio | 2.09% as on Nov 30, 2025 |
| Plan type | Regular |
| Risk | Very High |
| Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
| Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
| Period | This fund | Category average |
|---|---|---|
| 1 Month | -0.52% | -0.5% |
| 3 Months | 1.3% | -0.18% |
| 6 Months | 7.83% | 2.26% |
| 1 Year | 5.2% | -2.19% |
| 2 Years | 26.49% | 17.69% |

Large Cap 38.25%
Mid Cap 25.3%
Small Cap 34.76%
Other Cap 0%
Healthcare 98.31%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Repo 1.91%
Others 1.91%

| Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|
| HDFC Pharma And Healthcare Fund | -0.52% | 7.83% | 5.2% | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | -1.23% | 4.82% | 3.39% | 26.7% | 18.92% | 15.06% |
| SBI Healthcare Opportunities Fund | -1.1% | 3.97% | 0.86% | 23.76% | 18.07% | 11.44% |
| DSP Healthcare Fund | -0.08% | 4.88% | -4.97% | 20.67% | 16.37% | 14.69% |
| Tata India Pharma & Healthcare Fund | -1.43% | 4.98% | -0.15% | 21.51% | 16.34% | 11.83% |
| Nippon India Pharma Fund | -0.66% | 2.62% | -0.17% | 21.01% | 16.31% | 13.46% |
| Fund name | Std. deviation | Beta | Sharpe | Sortino |
|---|---|---|---|---|
| HDFC Pharma And Healthcare Fund | N.A. | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.69 | 0.95 | 1.21 | 1.78 |
| SBI Healthcare Opportunities Fund | 14.09 | 0.85 | 1.16 | 1.86 |
| DSP Healthcare Fund | 14.58 | 0.84 | 0.96 | 1.68 |
| Tata India Pharma & Healthcare Fund | 16.04 | 0.97 | 0.92 | 1.47 |
| Nippon India Pharma Fund | 15.23 | 0.91 | 0.94 | 1.42 |
| Fund name | ETM Rank | AUM | Fund age | Expense ratio |
|---|---|---|---|---|
| HDFC Pharma And Healthcare Fund | N.A. | 1,967 Cr | 2 yrs 2 m | 2.09% |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 6,437 Cr | 7 yrs 5 m | 1.86% |
| SBI Healthcare Opportunities Fund | N.A. | 4,082 Cr | 26 yrs 6 m | 1.93% |
| DSP Healthcare Fund | N.A. | 3,144 Cr | 7 yrs 1 m | 1.91% |
| Tata India Pharma & Healthcare Fund | N.A. | 1,325 Cr | 10 yrs | 2.1% |
| Nippon India Pharma Fund | N.A. | 8,346 Cr | 21 yrs 7 m | 1.81% |
Risk ratios are based on three-year data. The required data is unavailable for the scheme.
| Fund AUM | 1,967 Cr as on Oct 31, 2025 |
| Scheme document | View Scheme Document |
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
| No. of schemes | 78 view all schemes |
| Total AUM | 8,93,028 Cr as on Sep 30, 2025 |
| Address | "HDFC House", 2nd Floor, H. T. Parekh Marg, 165-166, Backbay Reclamation, Churchgate Mumbai, 400020 |
| shareholders.relations@hdfcfund.com | |
| Phone | 022 ? 66316333 |
| Fund name | ETM Rank | AUM | 1Y | 5Y |
|---|---|---|---|---|
| HDFC Infrastructure Fund | N.A. | 2,586 Cr | -0.25% | 29.77% |
| HDFC Mid Cap Fund | N.A. | 89,383 Cr | 7.6% | 26.43% |
| HDFC Small Cap Fund | N.A. | 38,412 Cr | -1.11% | 26.37% |
| HDFC Focused Fund | N.A. | 25,140 Cr | 8.48% | 25.91% |
| HDFC Flexi Cap Fund | N.A. | 91,041 Cr | 9.08% | 25.16% |
| HDFC ELSS Tax Saver Fund | N.A. | 17,194 Cr | 7.58% | 23.17% |
The current Net Asset Value (NAV) of the HDFC Pharma And Healthcare Fund plan is approximately ₹17.423 as of Dec 04, 2025.
The HDFC Pharma And Healthcare Fund is a 2 yrs 2 m old fund and has delivered average annual returns of 29.09% since inception.
| 1-Year | Since Inception |
|---|---|
| 5.2% | 29.09% |
The HDFC Pharma And Healthcare Fund has an expense ratio of 2.09%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The HDFC Pharma And Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 1,967 Cr as on Oct 31, 2025.
The HDFC Pharma And Healthcare Fund has invested the majority of its money in the stocks of the following companies -
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.7% |
| Divi's Laboratories Ltd. | 8.87% |
| Lupin Ltd. | 6.67% |
| Glenmark Pharmaceuticals Ltd. | 6.05% |
| Alkem Laboratories Ltd. | 5.83% |
| Max Healthcare Institute Ltd. | 5.49% |
| Ipca Laboratories Ltd. | 4.12% |
| Laurus Labs Ltd. | 3.8% |
| Aster DM Healthcare Ltd. | 3.71% |
| Torrent Pharmaceuticals Ltd. | 3.63% |
The HDFC Pharma And Healthcare Fund has primarily invested in the following sectors
| Sector | Percentage of Portfolio |
|---|---|
| Healthcare | 98.31% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
Redeeming your investments in the HDFC Pharma And Healthcare Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.
